Latest podcast episode – Tailoring drug therapy to your genes

Research / 03 August 2021

Photo: iStock

Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.


Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.

 

Subscribe by visiting the Drug Safety Matters website or listen in right here:

 

Read more

Pharmacogenomics group aims to refine patient safety options

Africa integral to evolution of pharmacogenomics research

You may also like


Medication error reporting for patients in Africa – the time to act is now

With low reporting of medication errors in Africa, understanding the scale of the problem and the reasons behind it should help in efforts to improve the situation.

Research / 31 August 2022

Fruitful start for EHDEN-powered signal discovery

In a weeklong groundbreaking study-a-thon with the IMI EHDEN consortium, UMC researchers found longitudinal health data could boost preliminary analysis of drug-event combinations.

Research / 28 October 2022

Unmasking data in the COVID-19 vaccine era

First came the COVID-19 pandemic. Then came the COVID-19 vaccines. Then came millions of COVID-19 vaccine reports of suspected side effects. What are the implications of that?

Research / 25 November 2022

Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more